Action Point Financial Planning’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
Action Point Financial Planning's TGTX Position: Q3 2026 in Review
Action Point Financial Planning sold out of TG Therapeutics (TGTX) in Q3 2026, closing a stake of 13 shares — an estimated $659 sold.
Action Point Financial Planning first reported a position in TGTX in Q2 2026 and held it in 1 quarter. The position peaked at $659 in Q2 2026. 455 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.
- Action Point Financial Planning reported no remaining TG Therapeutics position as of Q3 2026 after selling out during the quarter.
- Action Point Financial Planning sold 13 TG Therapeutics shares in Q3 2026, an estimated $659.
- Action Point Financial Planning first reported a position in TG Therapeutics in Q2 2026 and held it in 1 quarter.
- Action Point Financial Planning's TG Therapeutics position peaked at $659 in Q2 2026.
- 455 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.
Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.